Polymorphisms Affecting the Response to Novel Antiepileptic Drugs

Epilepsy is one of the most frequent chronic neurologic disorders that affects nearly 1% of the population worldwide, especially in developing countries. Currently, several antiepileptic drugs (AEDs) are available for its therapy, and although the prognosis is good for most patients, 20%–30% amongst...

Descripción completa

Detalles Bibliográficos
Autores principales: Urzì Brancati, Valentina, Pinto Vraca, Tiziana, Minutoli, Letteria, Pallio, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917302/
https://www.ncbi.nlm.nih.gov/pubmed/36768858
http://dx.doi.org/10.3390/ijms24032535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917302/
https://www.ncbi.nlm.nih.gov/pubmed/36768858
http://dx.doi.org/10.3390/ijms24032535

Ejemplares similares